HLA-B27-associated cardiac disease

Annals of Internal Medicine

Volumn 127, Issue 8 I, 1997, Pages 621-629

  Bergfeldt, Lennart ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

AORTA VALVE REGURGITATION; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; CARDITIS; HEART ARRHYTHMIA; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOGENETICS; MITRAL VALVE REGURGITATION; PACEMAKER; PERICARDITIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE;

EID: 0030803209     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-127-8_part_1-199710150-00007     Document Type: Review

References (107)

1. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973;1:904-7.
2. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288: 704-6.
3. Moll JM, Haslock I, Macrae IF, Wright V. Associations between ankytosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome. Medicine (Baltimore). 1974;53:343-64.
4. Wright V. Relationships between ankylosing spondylitis and other spondarthritides. In: Moll JM, ed. Ankylosing Spondylitis. New York: Churchill Livingstone; 1980:42-51.
5. Baur MP, Neugebauer M, Deppe H, Sigmund M, Luton T, Mayr WR, et al. Population analysis on the basis of deduced haplotypes from random families. In: Albert ED, Baur MP, Mayr WR, eds. Histocompatibility Testing. 1984. New York: Springer-Verlag, 1984:333-41.
6. Svejgaard A, Ryder LP. Associations between HLA and disease: notes on methodology and a report from the HLA and disease registry. In: Dausset J, Svejgaard A, eds. HLA and Disease. Baltimore: Williams & Wilkins; 1977:46-71.
7. Tsujimoto M. Epidemiological research on the prevalence of ankylosing spondylitis. Med J Osaka Univ. 1978;28:363-81.
8. Ebringer A. Theoretical models to explain the association of HLA-B27 with ankylosing spondylitis. Scand J Rheumatol Suppl. 1990;87:151-63.
9. Mallory TB. Case records of the Massachusetts General Hospital. N Engl J Med. 1936;214:690-8.
10. Davidson P, Baggenstoss AH, Slocumb CH, Daugherty GW. Cardiac and aortic lesions in rheumatoid spondylitis. Proceedings of the Staff Meetings of the Mayo Clinic. 1963;38:427-35.
11. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48:1014-27.
12. Bergfeldt L, Edhag O, Rajs J. HLA-B27-associated heart disease. Clinicopathologic study of three cases. Am J Med. 1984;77:961-7.
13. Paulus HE, Pearson CM, Pitts W Jr. Aortic insufficiency in five patients with Reiter's syndrome. A detailed clinical and pathologic study. Am J Med. 1972;53:464-72.
14. Thomas D, Hill W, Geddes R, Sheppard M, Arnold J, Fritzsehe J, et al. Early detection of aortic dilatation in ankylosing spondylitis using echocardiography. Aust N Z J Med. 1982;12:10-3.
15. Tucker CR, Fowles RE, Calin A, Popp RL. Aortitis in ankylosing spondylitis: early detection of aortic root abnormalities with two dimensional echocardiography. Am J Cardiol. 1982;49:680-6.
16. LaBresh KA, Lally EV, Sharma SC, Ho G Jr. Two-dimensional echocardiographic detection of preclinical aortic root abnormalities in rheumatoid variant diseases. Am J Med. 1985;78:908-12.
17. Graham DC, Smythe HA. The carditis and aortitis of ankylosing spondylitis. Bull Rheum Dis. 1958;9:171-4.
18. Kinsella TD, Johnson LG, Sutherland IR. Cardiovascular manifestations of ankylosing spondylitis. Can Med Assoc J. 1974;111:1309-11.
19. Bachmann F, Hartl W, Veress M, Frind W. Kardiovaskuläre Komplikationen bei Spondylitis Ankylosans (Morbus Bechterew) [Cardiovascular complications of ankylosing spondylitis (Bechterew's disease)]. Med Welt. 1976; 27:2149-50.
20. Good AE. Reiter's disease: a review with special attention to cardiovascular and neurologic sequelae. Semin Arthritis Rheum. 1974;3:263-86.
21. Schilder DP, Harvey WP, Hufnagel CA. Rheumatoid spondylitis and aortic insufficiency. N Engl J Med. 1956;255:11-7.
22. Qaiyumi S, Hassan ZU, Toone E. Seronegative spondyloarthropathies in lone aortic insufficiency. Arch Intern Med. 1985;145:822-4.
23. Bergfeldt L, Insulander P, Lindblom D, Möller E, Edhag O. HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med. 1988;85:12-8.
24. Calin A, Fries JF, Stinson EB, Payne R. Normal frequency of HL-A B27 in aortic insufficiency (Letter). N Engl J Med. 1976;294:397.
25. Hollingworth P, Hall PJ, Knight SC, Newman R. Lone aortic regurgitation, sacroiliitis, and HLA B27. Case history and frequency of association. Br Heart J. 1979;42:229-30.
26. Tan PL, Butler MJ, Woodfield DG, Jacobson C, Grigor RR, Caughey DE. HLA antigens in isolated aortic incompetence [Letter]. J Rheumatol. 1980;7:757-8.
27. Eversmeyer WH, Rosenstock D, Biundo JJ Jr. Aortic insufficiency with mild ankylosing spondylitis in black men. JAMA. 1978;240:2652-3.
28. Block SR. Reiter's syndrome and acute aortic insufficiency. Arthritis Rheum. 1972;15:218-20.
29. Stewart SR, Robbins DL, Castles JJ. Acute fulminant aortic and mitral insufficiency in ankylosing spondylitis. N Engl J Med. 1978;299:1448-9.
30. Reid GD, Patterson MW, Patterson AC, Cooperberg PL. Aortic insufficiency in association with juvenile ankylosing spondylitis. J Pediatr. 1979;95:78-80.
31. Kean WF, Anastassiades TP, Ford PM. Aortic incompetence in HLA B27-positive juvenile arthritis. Ann Rheum Dis. 1980;39:294-5.
32. Gore JE, Vizcarrondo FE, Rieffel CN. Juvenile ankylosing spondylitis and aortic regurgitation: a case presentation. Pediatrics. 1981;68:423-6.
33. Gregersen PK, Gallerstein P, Jaffe W, Enlow RW. Valvular heart disease associated with juvenile onset ankylosing spondylitis: a case report and review of the literature. Bull Hosp Jt Dis Orthop Inst. 1982;43:103-14
34. Demouin JC, Lespagnard J, Bertholet M, Soumagne D. Acute fulminant aortic regurgitation in ankylosing spondylitis. Am Heart J. 1983;105:859-61.
35. Pelkonen P, Byring R, Pesonen E, Leijala M, Haapasaari J, Rapidly progressive aortic incompetence in juvenile ankylosing spondylitis: a case report. Arthritis Rheum. 1984;27:695-700.
36. Hübscher O, Graci y Susini J. Aortic insufficiency in Reiter's syndrome of juvenile onset. J Rheumatol. 1984;11:94-5.
37. Simpson J, Borzy MS, Silberbach GM. Aortic regurgitation at diagnosis of HLA-B27 associated spondyloarthropathy. J Rheumatol. 1995;22:332-4.
38. Stamato T, Laxer RM, de Freitas C, Gow R, Silverman ED, Luy L, et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am J Cardiol 1995;75:744-6.
39. Kawasuji M, Hetzer R, Oelert H, Stauch G, Borst HG. Aortic valve replacement and ascending aorta replacement in ankylosing spondylitis: report of three surgical cases and review of the literature. Thorac Cardiovasc Surg. 1982;30:310-4.
40. Roberts WC, Hollingsworth JF, Bulkley BH, Jaffe RB, Epstein SE, Stinson EB. Combined mitral and aortic regurgitation in ankylosing spondylitis. Angiographic and anatomic features. Am J Med. 1974;56:237-43.
41. Porciello PI, Capella G, Aralda D, Rossi P. Mitral and aortic regurgitation: a rare association in ankylosing spondylitis. G Ital Cardiol. 1978;8:564-7.
42. Haruta S, Kasanuki H, Kusumoto M, Sato K, Ohnishi T, Shibata N, et al. A case of ankylosing spondylitis with aortic and mitral regurgitation, right coronary ostial occlusion, and intrahissian block. Nippon Naika Gakkai Zasshi. 1981;70:888-94.
43. Shah A. Echocardiographic features of mitral regurgitation due to ankylosing spondylitis. Am J Med. 1987;82:353-6.
44. Bernstein L, Broch OJ. Cardiac complications in spondylarthntis ankylopoietica. Acta Med Scand. 1949;135:185-94.
45. Thomsen NH, Hörstev-Petersen K, Simonsen EE. Complete heart block in Reiter's syndrome. Dan Med Bull. 1985;32:272-3.
46. O'Neill TW, Bresnihan B. The heart in ankylosing spondylitis. Ann Rheum Dis. 1992;51;705-6.
47. Bergfeldt L, Edhag O, Vallin H. Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis. A 25-year follow-up study of 68 patients. Acta Med Scand. 1982;212:217-23.
48. Cass RM, Richeson JF, Akiyama T. Reversible complete heart block. Hosp Pract (Off Ed). 1991;26:51.
49. Weed CL, Kulander BG, Mazzarella JA, Decker JL. Heart block in ankylosing spondylitis. Arch Intern Med. 1966;117:800-6.
50. Sukenik S, Pras A, Buskila D, Katz A, Snir Y, Horowitz J. Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol. 1987;6:588-92.
51. Hassel D, Heinsimer J, Califf RM, Benson A, Rice J, German L. Complete heart block in Reiter's syndrome. Am J Cardiol. 1984;53:967-8.
52. Nielsen H. Complete heart block in Reiter's syndrome. Acta Cardiol. 1986; 16:451-5.
53. Haverman JF, Van Albada-Kuipers GA, Dohmen HJ, Dijkmans BA. Atrioventricular conduction disturbance as an early feature of Reiter's syndrome. Ann Rheum Dis. 1988;47:1017-20.
54. Bergfeldt L, Edhag O, Vedin L, Vallin H. Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men. Am J Med. 1982;73:187-91.
55. Bergfeldt L. HLA B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakers. Am J Med. 1983;75:210-5.
56. Bergfeldt L, Möller E. Complete heart block-another HLA B27 associated disease manifestation. Tissue Antigens. 1983;21:385-90.
57. Peeters AJ, ten Wolde S, Sedney MI, de Vries RR, Dijkmans BA. Heart conduction disturbance: an HLA-B27 associated disease. Ann Rheum Dis. 1991;50:348-50.
58. Sahi SP, Winfield CR. Third-degree heart block developing in an HLA-B27-positive individual with a family history of ankylosing spondylitis. Br J Clin Pract. 1990;44:794-5.
59. Michels W, Driscoll DJ. Genetics of heart disease. In: Brandenburg RO, Fuster V, Giuliani ER, McGoon DC, eds. Cardiology: Fundamentals and Practice. Chicago: Year Book Medical Publishers; 1987:1895-915.
60. Bergfeldt L, Möller E. Pacemaker treated women with heart block have no increase in the frequency of HLA-B27 and associated rheumatic disorders in contrast to men - a sex-linked difference in disease susceptibility. J Rheumatol. 1986;13:941-3.
61. Rossen RM, Goodman DJ, Harrison DC. A-V conduction disturbances in Reiter's syndrome. Am J Med. 1975;58:280-4.
62. Harvey DB, Hollenberg M, Kunkel F, Scheinman MM. Ankylosing spondylitis with complete heart block. Arch Intern Med. 1976;136:1046-50.
63. Godeau P, Bletry O, Herreman G. Troubles de conduction intracardiaques au cours de la spondylarthrite ankylosante. [Disorders of intracardiac conduction during ankylosing spondylarthritis. Apropos of 19 cases.] Ann Med Interne (Paris). 1976;127:203-14.
64. Mazieres B, Constans R, Donzeau JP, Sacau P, Dardenne P, Arlet J. Étude électrophysiologique de deux cas de bloc auricolo-ventriculaire secondaire a une spondylarthrite ankylosante. [Electrophysiological study of 2 cases of atrio-ventricular block in ankylosing spondylarthritis.] Rev Rhum Mal Osteoartic. 1979;46:137-40.
65. Nitter-Hauge S, Otterstad JE. Characteristics of atrioventricular conduction disturbances in ankylosing spondylitis (Mb. Bechterew). Acta Med Scand. 1981;210:197-200.
66. Bergfeldt L, Vallin H, Edhag O. Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristics. Br Heart J. 1984;51:184-8.
67. Puech P. Atrioventricular block: the value of intracardiac recordings. In: Krikler DM, Goodwin JF, eds. Cardiac Arrhythmias: The Modern Electrophysiological Approach. Philadelphia: WB Saunders; 1975:81-115.
68. Przybyla AC, Paulay KL, Stein E, Damato AN. Effects of digoxin on atrioventricular conduction patterns in man. Am J Cardiol. 1974;33:344-50.
69. Karpawich PP, Gillette PC, Garson A Jr, Hesslein PS, Porter CB, McNamara DG. Congenital complete atrioventricular block: clinical and electrophysiologic predictors of need for pacemaker insertion. Am J Cardiol. 1982;48:1098-102.
70. Rosen KM, Loeb HS, Chuquimia R, Sinno MZ, Rahimtoola SH, Gunnar RM. Site of heart block in acute myocardial infarction. Circulation. 1970;42: 925-33.
71. Bergfeldt L, Allebeck P, Edhag O. Mortality in pacemaker-treated patients. A follow-up study of the impact of HLA B27 and associated rheumatic disorders. Acta Med Scand. 1987;222:293-9.
72. Rajs J, Karlsson T, Bergfeldt L. Cardiopathological findings in a patient suffering of HLA B27 associated heart disease. In: Somogyi E, Sótony P, eds. Proceedings of the ISNUD Workshop on Sudden Cardiac Death. Budapest: ISNUD Workshop; 1994:146-53.
73. Engfeldt B, Romanus R, Ydén S. Histological studies of pelvo-spondylitis ossificans (ankylosing spondylitis) correlated with clinical and radiological findings. Ann Rheum Dis. 1954;13:219-28.
74. Cruickshank B. Pathology of ankylosing spondylitis. Bull Rheum Dis. 1960; 10:211-4.
75. Cruickshank B. Pathology of ankylosing spondylitis. Clin Orthop. 1971;74: 43-58.
76. Bergfeldt L, Rosenqvist M. Atrial arrhythmias - the dominating cardiac problem in three patients with HLA B27 associated rheumatic disorders. Acta Med Scand. 1988;224:627-30.
77. Takkunen J, Vuopala U, Isomäki H. Cardiomyopathy in ankylosing spondylitis. I. Medical history and results of clinical examination in a series of 55 patients. Ann Clin Res. 1970;2:106-12.
78. Ribeiro P, Morley KD, Shapiro LM, Garnett RA, Hughes GR, Goodwin JF. Left ventricular function in patients with ankylosing spondylitis and Reiter's disease. Eur Heart J. 1984;5:419-22.
79. Brewerton DA, Gibson DG, Goddard DH, Jones TJ, Moore RB, Pease CT, et al. The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study. Lancet. 1987;1:995-8.
80. Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis. 1992;51:227-32.
81. Nagyhegyi G, Nadas I, Banyai F, Luzsa G, Geher P, Molnar J, et al. Cardiac and cardiopulrnonary disorders in patients with ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol. 1988;6:17-26.
82. Crowley JJ, Donnelly SM, Tobin M, FitzGerald O, Bresnihan B, Maurer BJ, et al. Doppler echocardiographic evidence of left ventricular diastolic dysfunction in ankylosing spondylitis. Am J Cardiol. 1993;71: 1337-40.
83. Sun JP, Khan MA, Farhat AZ, Bahler RC. Alterations in cardiac diastolic function in patients with ankylosing spondylitis. Int J Cardiol. 1992;37:65-72.
84. Wilkinson M, Bywaters EG. Clinical features and course of ankylosing spondylitis as seen in a follow up of 222 hospital referred cases. Ann Rheum Dis 1958;17:209-28.
85. Ebringer A, Growling P, Ngwa Sun N, James DC, Ebringer RW. Cross-reactivity between Klebsiella aerogenes species and B27 lymphocyte antigens as an aetiological factor in ankylosing spondylitis [Abstract]. In: Dausset J, Svejgaard A, eds. HLA and Disease: Predisposition to Disease and Clinical Implications. Pans: Editions INSERM; 1976:27.
86. Noer HR. An "experimental" epidemic of Reiter's syndrome. JAMA. 1966; 198:693-8.
87. Sairanen E, Paronen I, Mähönen H. Reiter's syndrome: a follow-up study Acta Med Scand. 1969;185:57-63.
88. Calin A, Fries JF. An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors. Ann Intern Med. 1976;84:564-6.
89. Vartiainen J, Hurri L. Arthritis due to Salmonella typhimurium. Report of 12 cases of migratory arthritis in association with Salmonella typhimurium infection. Acta Med Scand. 1964;175:771-6.
90. Briem H, Evengård B, Jonsson M. Reiter's syndrome complicating Salmonella enteritidis infection [Letter]. Lancet. 1978;2:112.
91. Ahvonen P, Sievers K, Aho K. Arthritis asociated with Yersinia enterocolitica infection. Acta Rheumatol Scand. 1969;15:232-53.
92. Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A. HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum. 1974;17:521-6.
93. Strominger JL Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases. J Clin Invest. 1986;77:1411-5.
94. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990;11:137-42.
95. McMichael A, Bell J. HLA B27: a disease-associated immune response gene. Res Immunol. 1991;142:475-82.
96. Woodrow JC. Genetics of the spondyloarthropathies. Curr Opin Rheumatol. 1991;3:586-91.
97. The pathogenetic role of HLA-B27. Proceedings of the Fifth Bertine Koperberg Conference. May 21-23, 1990, Oosterbeek, the Netherlands. Scand J Rheumatol Suppl. 1990;87:1-163.
98. Laitinen O, Leirisalo M, Skylv G. Relation between HLA-B27 and clinical features in patients with Yersinia arthritis. Arthritis Rheum. 1977;20: 1121-4.
99. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell. 1990;63:1099-112.
100. Lakomek HJ, Plomann M, Specker C, Schwochau M. Ankylosing spondylitis: an autoimmune disease? Ann Rheum Dis. 1991;50:776-81.
101. Goodacre JA, Mander M, Dick WC. Patients with ankylosing spondylitis show individual patterns of variation in disease activity. Br J Rheumatol. 1991;30:336-8.
102. Bergfeldt L, Edhag O, Holm G, Norberg R. Platelet aggregating activity in serum from patients with HLA-B27 associated rheumatic and cardiac disorders: a possible link to the proliferate vascular changes. Br Heart J. 1991;65:184-7.
103. Ruppert GB, Lindsay J, Barth WF. Cardiac conduction abnormalities in Reiter's syndrome. Am J Med. 1982;73:335-40.
104. Bergfeldt L. Disturbances of the Cardiac Conduction System in HLA-B27 Associated Disease. Studies on Prevalence, Association with HLA B27, and Electrophysiological Characteristics [Thesis]. Stockholm: Reproprint; 1982.
105. Bernstein L. Cardiac complications in spondylarthritis ankylopoietica. Rheumatism. 1951;7:18-23.
106. Sobin LH, Hagstrom JW. Lesions of cardiac conduction tissue in rheumatoid aortitis. JAMA. 1962;180:1-5.
107. von Leitner ER, Kötter V, Schröder R. Kardiale Spätmanifestationen des Morbus Reiter. [Late cardiac manifestations of Reiter's disease]. Dtsch Med Wochenschr. 1981;106:939-41.